Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 1 mg/ml;  ;   - eye drops, solution - 1 mg/ml - active: diclofenac sodium 1 mg/ml     excipient: benzalkonium chloride disodium edetate dihydrate hydrochloric acid hydroxypropyl gamma-cyclodextrin propylene glycol trometamol tyloxapol water for injection

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 1 mg/ml;   - eye drops, solution - 300 mcg/0.3ml - active: diclofenac sodium 1 mg/ml   excipient: boric acid polyoxyl 35 castor oil trometamol water for injection - voltaren ophtha eye drops are indicated for: · post-operative inflammation in cataract surgery and other surgical interventions. · prevention of cystoid macular oedema after cataract extraction with lens implantation. · post-traumatic inflammation in non-penetrating wounds. · inhibition of miosis in cataract surgery. · relief of pain and photophobia. · non-infected inflammatory conditions of the anterior segment of the eye.

Israël - anglais - Ministry of Health

bioavenir ltd, israel - diclofenac sodium - solution - diclofenac sodium 0.1 %v/v - diclofenac - diclofenac - post-operative inflammation following cataract extraction. control of ocular pain and discomfort associated with corneal epithelial defects after laser excimer prk or accidental trauma.

Irlande - anglais - HPRA (Health Products Regulatory Authority)

laboratoires thea - diclofenac sodium - eye drops, solution - 1 milligram(s)/millilitre - antiinflammatory agents, non-steroids; diclofenac

Australie - anglais - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 1 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; disodium edetate; hydroxypropylbetadex; hydrochloric acid; propylene glycol; trometamol; tyloxapol; water for injections - post-operative inflammation in cataract surgery and other surgical interventions.

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

devatis limited - diclofenac sodium 1 mg/ml - eye drops, solution - 0.3 mg/0.3ml - active: diclofenac sodium 1 mg/ml excipient: boric acid polyoxyl 35 castor oil trometamol water for injection - diclofenac devatis 0.1% (1 mg/ml) eye drops, unit-dose eye drops are indicated for: · post-operative inflammation in cataract surgery and other surgical interventions. · prevention of cystoid macular oedema after cataract extraction with lens implantation. · post-traumatic inflammation in non-penetrating wounds. · inhibition of miosis in cataract surgery. · relief of pain and photophobia. · non-infected inflammatory conditions of the anterior segment of the eye.